Whale Or Porpoise Oil Or Solidified Form Thereof Patents (Class 424/524)
  • Patent number: 11426346
    Abstract: A lutein-containing ophthalmic composition, wherein the ophthalmic composition is mainly consisting of a natural anti-inflammatory substance, a substance with increasing liquid viscosity, and an artificial tear. The substance with increasing liquid viscosity could apply the ophthalmic composition to elongate the retention time on the ocular surface, thereby increasing the retention time of anti-inflammatory substance on the ocular surface for treating dry eye syndrome and inhibiting ocular surface inflammation.
    Type: Grant
    Filed: October 13, 2019
    Date of Patent: August 30, 2022
    Assignee: TAIPEI MEDICAL UNIVERSITY
    Inventors: Ching-Li Tseng, I-Chan Lin, Yi-Zhou Chen, Yu-Lun Chuang, Cheng-Han Tsai, Zhi-Yu Chen
  • Patent number: 11286412
    Abstract: According to one or more embodiments of the present disclosure, water-based drilling fluids may include an aqueous base fluid and one or more additives. In embodiments, water-based drilling fluids may include a lubricant blend including at least oleic acid and palmitoleic acid. The sum of the volume percent of the oleic acid and palmitoleic acid may be from 0.1 vol. % to 10 vol. % of the total volume of the water-based drilling fluid. In embodiments, water-based drilling fluids may include a lesser melting point fraction of jojoba oil in an amount of from 0.1 vol. % to 10 vol. % relative to the total volume of the water-based drilling fluid. At least 90% of the lesser melting point fraction of jojoba oil may have a melting point less than or equal to 15° C. Methods for drilling subterranean wells with the water-based drilling fluids are also disclosed.
    Type: Grant
    Filed: November 4, 2019
    Date of Patent: March 29, 2022
    Assignee: Saudi Arabian Oil Company
    Inventors: Md Amanullah, Raed Alouhali, Sara Alkhalaf, Ali Radhwan, Mohammed Khalid Al-Arfaj, Abdulaziz S. Al-Qasim
  • Patent number: 8703095
    Abstract: The invention relates to an oil-in-water adjuvant emulsion which comprises at least: squalene, an aqueous solvent, a polyoxyethylene alkyl ether nonionic surfactant, a hydrophobic nonionic surfactant, which emulsion is thermoreversible, and wherein 90% of the population by volume of the oil drops has a size less than 200 nm. The invention also relates to a process for preparing an immunogenic composition according to which at least one vaccine antigen is mixed with an oil-in-water emulsion, wherein the oil-in-water emulsion is obtained by means of a temperature-variation phase-inversion process.
    Type: Grant
    Filed: July 7, 2006
    Date of Patent: April 22, 2014
    Assignee: Sanofi Pasteur S.A.
    Inventors: Marie-Francoise Klucker, Francois Dalencon, Patricia Probeck-Quellec
  • Patent number: 8653226
    Abstract: A polyesteracetal contains —[C(O)(CR3R4)x(C(O))yOCR1R2O]— repeating unit where x is 0 to 5, y is 0 or 1, and R1, R2, R3 and R4 are independently H, C1 to C24 alkyl, C2 to C24 alkenyl, C6 to C14 aryl, C7 to C24 alkylaryl, heteroatom interrupted C1 to C24 alkyl, heteroatom interrupted C2 to C24 alkenyl, heteroatom interrupted C4 to C14 aryl, or heteroatom interrupted C5 to C24 alkylaryl, and wherein on average x>1 or y>0. The polyesteracetal can be a homopolymer or copolymer. A method of preparing the polyesteracetal comprises a ring-opening polymerization of a cyclic esteracetal monomer using a metal alkolate, metal alkoxide or metal alkyl initiator.
    Type: Grant
    Filed: December 2, 2009
    Date of Patent: February 18, 2014
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Stephen A. Miller, Ryan T. Martin
  • Publication number: 20120128763
    Abstract: A formulation has been developed for treatment of the symptoms of dry eye which incorporates the natural product jojoba wax, or components thereof, to enhance the spreading of the artificial tear and eyedrop as well as stabilize the eyedrop. The improved performance of the jojoba wax supplemented tear relieves irritation and discomfort as well as sharpens the blurred vision.
    Type: Application
    Filed: February 2, 2012
    Publication date: May 24, 2012
    Inventor: Steven Maskin
  • Patent number: 7718195
    Abstract: A process for separating non-denatured fat and lipids as well as non-denatured proteins from a material of organic origin is disclosed wherein the fat and proteins are separated at a temperature below the denaturing temperature for the proteins to conserve their biological function and nutritional value.
    Type: Grant
    Filed: October 21, 1999
    Date of Patent: May 18, 2010
    Assignee: Denofa AS
    Inventors: Stig Jansson, Edel Elvevoll
  • Patent number: 7179491
    Abstract: Triglyceride oil derived from marine sources, mammalian and fish, is treated with a silica at relatively low temperature under vacuum and is then further treated with a bleaching clay under vacuum and at higher temperature. The silica and the bleaching clay are then separated from the oil. The oil treated by this method is essentially free of proteinaceous materials, phosphatides and mucilage, pro-oxidant metals and very low in colored compounds, and is suitable for deodorizing. The deodorized oil is completely bland, unchanged in the concentration of the long-chain highly unsaturated fatty acids (EPA, DPA and DHA), very low in color, peroxides and secondary oxidation products, free of pesticides and has very good flavor stability. The method avoids the use of any chemicals, such as in the acid and base treatments required in conventional degumming and alkali refining of oils of marine origin. This avoids the formation of artifacts in the oil and trace contamination with chemicals.
    Type: Grant
    Filed: January 28, 2000
    Date of Patent: February 20, 2007
    Inventor: Ted Mag
  • Patent number: 6770278
    Abstract: The invention is directed to methods of using Ig compositions to prevent and/or treat humans, livestock and/or domesticated animals suffering from stress induced respiratory disorders. The Ig composition comprises a concentrated amount of one or more immunoglobulins selected from the group consisting of alpha, beta, and gamma globulins. Preferably, the Ig composition comprises other antibodies identified as providing an immune response and/or immune factors such as complement and transfer factors. The Ig composition preferably includes immunoglobulins specific to a variety of antigens. In a preferred method, an equine Ig composition is used to treat exercise induced pulmonary hemorrhage in horses.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: August 3, 2004
    Assignee: Central Biomedia, Inc.
    Inventor: William G. Skelly
  • Patent number: 6703052
    Abstract: A mixture of monounsaturated alcohols with 14 to 24 linear carbons in the linear chain is represented by jojoba alcohol, which remains an oily liquid at moderate ambient temperature. Jojoba alcohol is prepared by chemical hydrogenolysis of jojoba oil using a metal hydride reducing agent. A similar mixture of long chain monounsaturated alcohols can be prepared by hydrogenolysis of sperm whale oil. Mixtures of long chain monounsaturated alcohols penetrate epidermal layers of the skin to the vascular cells underneath where herpes viral infection, pain and other disorders occur.
    Type: Grant
    Filed: February 21, 2001
    Date of Patent: March 9, 2004
    Inventor: Anthony J. Verbiscar
  • Patent number: 6429193
    Abstract: A precementum- and/or cementum-derived chemotactic factor (CCTF) of a tooth of a Mammalian is characterized by a molecular weight measured by SDS-PAGE of 67000±1000. A process for purifying a precementum- and/or cementum-derived gingival fibroblast chemotactic factor (CCTF) of a Mammalian tooth includes eluting a protein mixture from precementum and/or cementum of a Mammalian tooth and purifying the precementum- and/or cementum-derived chemotactic factor (CCTF) from the eluted protein mixture by molecular weight fractionation, ion-exchange adsorption chromatography and hydroxyapatite adsorption chromatography. In the process for purifying the gingival fibroblast chemotactic factor (CCTF) the Mammalian is preferably a bovine.
    Type: Grant
    Filed: February 18, 2000
    Date of Patent: August 6, 2002
    Assignee: Kanebo, Ltd.
    Inventors: Masanobu Munekata, Kazuaki Nishimura
  • Patent number: 6046161
    Abstract: A method for increasing perfusion in a mammal suffering from cardiogenic shock by administering a perfusion-increasing effective amount of intermolecularly- or intramolecularly-crosslinked stroma-free hemoglobin to the mammal.
    Type: Grant
    Filed: February 27, 1998
    Date of Patent: April 4, 2000
    Assignee: Baxter International, Inc.
    Inventor: Robert J. Przybelski
  • Patent number: 6042855
    Abstract: A method of improving the tenderness of meat and meat products is described. The method includes administering excessive doses of vitamin D to meat producing animals prior to slaughter. The vitamin D causes greater calcium activated calpain activity which degrades certain myofibrillar proteins in the meat postmortem. The resulting meat has a significantly lower shear force in comparison to untreated meat.
    Type: Grant
    Filed: June 27, 1997
    Date of Patent: March 28, 2000
    Assignees: United States of America (USDA), Iowa State University Research Foundation, Inc.
    Inventors: Donald C. Beitz, Allen Trenkle, Frederick C. Parrish, Jayden L. Montgomery, Ronald L. Horst